学术急诊医学档案

Barthels, D. and H. Das (2020). "Current advances in ischemic stroke research and therapies." Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866(4): 165260.

Barton, G. M. and R. Medzhitov (2003). "Toll-like receptor signaling pathways." Science 300(5625): 1524–1525.

Bashkeran, T., et al. (2023). "Niosomes in cancer treatment: A focus on curcumin encapsulation." Heliyon 9(8).

Behrouzifar, S. and H. Esmaily (2024). "The biological efficacy of Apelin against focal transient cerebral ischemia–reperfusion injury. A systematic review and meta-analysis of animal studies." Brain Research 1833: 148887.

Bhardwaj, P., et al. (2020). "Niosomes: A review on niosomal research in the last decade." Journal of Drug Delivery Science and Technology 56: 101581.

Feigin, V. L., et al. (2021). "Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019." The Lancet Neurology 20(10): 795–820.

Feske, S. K. (2021). "Ischemic stroke." The American journal of medicine 134(12): 1457–1464.

Ge, X., et al. (2019). "Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery." Pharmaceutics 11(2).

Hameed, H., et al. (2024). "Liposomes like advanced drug carriers: from fundamentals to pharmaceutical applications." Journal of Microencapsulation 41(6): 456–478.

Hasseldam, H., et al. (2024). "N-acetyl aspartate levels early after ischemic stroke accurately reflect long-term brain damage." Heliyon 10(2).

Kleindorfer, D. O., et al. (2021). "2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association." stroke.

Kumar, G. P. and P. Rajeshwarrao (2011). "Nonionic surfactant vesicular systems for effective drug delivery—an overview." Acta Pharmaceutica Sinica B 1(4): 208–219.

Kushnazarova, R. A., et al. (2021). "Niosomes modified with cationic surfactants to increase the bioavailability and stability of indomethacin." Russian Chemical Bulletin 70(3): 585–591.

Li, C., et al. (2014). "Novel designed polyoxyethylene nonionic surfactant with improved safety and efficiency for anticancer drug delivery." International Journal of Nanomedicine 9(null): 2089–2100.

Longa, E. Z., et al. (1989). "Reversible middle cerebral artery occlusion without craniectomy in rats." stroke 20(1): 84–91.

Luo, Q., et al. (2018). "Apelin protects against sepsis‑induced cardiomyopathy by inhibiting the TLR4 and NLRP3 signaling pathways." Int J Mol Med 42(2): 1161–1167.

Mendelson, S. J. and S. Prabhakaran (2021). "Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review." Jama 325(11): 1088–1098.

Pinsky, D., et al. (2016). "Inflammatory Disequilibrium in Stroke." Circulation Research 119(1): 142–158.

Pires, P. C., et al. (2023). "Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability." Pharmaceuticals 16(10): 1424.

Powers, W. J., et al. (2019). "Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association." stroke 50(12): e344–e418.

Pundik, S., et al. (2012). "Reperfusion brain injury: focus on cellular bioenergetics." Neurology 79(13_supplement_1): S44–S51.

Riya, S., et al. (2022). "An overview on Niosomes: Novel Pharmaceutical drug delivery system." Journal of drug delivery & therapeutics 12: 171–177.

Sankhyan, A. and P. K. Pawar (2013). "Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization." DARU Journal of Pharmaceutical Sciences 21(1): 7.

Schneider, S., et al. (2021). "Determinants of long-term health-related quality of life in young ischemic stroke patients." Journal of Stroke and Cerebrovascular Diseases 30(2): 105499.

Shah, P., et al. (2021). "Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone." Int J Mol Sci 22(4).

Shao, Z.-Q., et al. (2021). "Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury." Neural Regeneration Research 16(6): 1044–1051.

Sun, J.-H., et al. (2021). "Gentianella acuta prevents acute myocardial infarction induced by isoproterenol in rats via inhibition of galectin-3/TLR4/MyD88/NF-кB inflammatory signalling." Inflammopharmacology 29(1): 205–219.

Wang, L., et al. (2022). "Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke." Antioxidants 11(12): 2377.

Wang, Y., et al. (2013). "TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion." Mediators of inflammation 2013(1): 124614.

Wang, Z., et al. (2023). "Shell-sheddable polymeric micelles alleviate oxidative stress and inflammation for enhanced ischemic stroke therapy." Nano Letters 23(14): 6544–6552.

Wu, M.-Y., et al. (2018). "Current mechanistic concepts in ischemia and reperfusion injury." Cellular Physiology and Biochemistry 46(4): 1650–1667.

Xu, S., et al. (2022). "Nano-liposomal encapsulation-delivered apelin-13 attenuates Ev71 infection-induced neurodegeneration by modulating Il-6 and Tlr7." Journal of Modern Nanotechnology 2(1).

Yafasova, A., et al. (2021). "Time to thrombolysis and long-term outcomes in patients with acute ischemic stroke: a nationwide study." stroke 52(5): 1724–1732.

Yan, Z., et al. (2021). "Neuroprotective Function of TNFAIP3 Interacting Protein 2 Against Oxygen and Glucose Deprivation/Reoxygenation-Induced Injury in Hippocampal Neuronal HT22 Cells Through Regulation of the TLR4/MyD88/NF-κB Pathway." Neuropsychiatric Disease and Treatment 17(null): 2219–2227.

Yang, C., et al. (2021). "Analgecine regulates microglia polarization in ischemic stroke by inhibiting NF-κB through the TLR4 MyD88 pathway." International Immunopharmacology 99: 107930.

Yu, M., et al. (2006). "HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2." Shock 26(2): 174–179.

Zhang, H., et al. (2018). "Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-kappaB Pathway and NLRP3 Inflammasome Activation." Cell Physiol Biochem 49(5): 1918–1932.

Zhang, J. J., et al. (2017). "Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-small ka, CyrillicB signaling pathway." PLoS One 12(2): e0172006.

Zhang, Y., et al. (2023). "Neuroprotective roles of apelin-13 in neurological diseases." Neurochemical Research 48(6): 1648–1662.

Zhou, K., et al. (2019). "Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia." Phytomedicine 59: 152922.